Beuchat, Isabelle http://orcid.org/0000-0002-9300-4443
Alloussi, Senubia
Reif, Philipp S.
Sterlepper, Nora
Rosenow, Felix
Strzelczyk, Adam http://orcid.org/0000-0001-6288-9915
Funding for this research was provided by:
Johann Wolfgang Goethe-Universität, Frankfurt am Main
Article History
Received: 22 December 2020
Accepted: 16 June 2021
First Online: 28 June 2021
Competing interests
: IB: reports a research grant from the Swiss National Science Foundation. SA: reports no conflict of interest. PSR: reports personal fees from Eisai. NS: reports no conflict of interest. FR: reports personal fees from Arvelle Therapeutics, Eisai, GW Pharmaceuticals, Novartis, Medtronic, and UCB, and grants from the Detlev-Wrobel-Fonds for Epilepsy Research, the Deutsche Forschungsgemeinschaft, the LOEWE Program of the State of Hesse, and the European Union. AS: reports personal fees and grants from Arvelle Therapeutics, Desitin Arzneimittel, Eisai, GW Pharmaceuticals companies, LivaNova, Marinus Pharma, Medtronic, UCB, and Zogenix.